Articles by Susan J. Schniepp - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Susan J. Schniepp

Insider Solutions Rule #1: Be in Compliance

Drug manufacturers have to be more than just "audit ready."
Nov 2, 2010

Drug manufacturers have to be more than just "audit ready."

Insider Solutions: The Quality Agreement

Before embarking on an outsourcing relationship, it's important to be aware of FDA's expectations.
Aug 2, 2010

Before embarking on an outsourcing relationship, it's important to be aware of FDA's expectations.

Inside USP: The USP Convention

Defining the Next Five Years.
May 2, 2010

Defining the Next Five Years.

USP Convention Sets Agenda for Next Five Years

Apr 29, 2010

The US Pharmacopeial Convention recently held its convention in Washington, DC.

ISPE Raises the Bar for Baseline Guides

New information improves an organization's guide to building manufacturing facilities.
Apr 2, 2010

New information improves an organization's guide to building manufacturing facilities.

Managing Change Control in a Changing Environment

We never thought implementing complex changes could become more cumbersome.
Feb 2, 2010

We never thought implementing complex changes could become more cumbersome.

Insider Solutions: A New Direction for USP?

With a five-yar revision cycle around the corner, USP will hit or miss the collaboration mark.
Nov 2, 2009

With a five-yar revision cycle around the corner, USP will hit or miss the collaboration mark.

Insider Solutions: Preventing the Next Heparin Scare

Determined to prevent further supply-chain breaches, industry takes charge, offers proposals.
Aug 2, 2009

Determined to prevent further supply-chain breaches, industry takes charge, offers proposals.

Insider Solutions: Device Database Can Help Pharma

Standards data is helpful, but FDA needs to apply its information across the board. This article contains bonus online-exclusive material.
Apr 2, 2009

Standards data is helpful, but FDA needs to apply its information across the board. This article contains bonus online-exclusive material.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
12%
To select process for new products only
23%
To select processes for both new and legacy products
21%
Do not use QbD
23%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Click here